UniProt ID | CNN3_HUMAN | |
---|---|---|
UniProt AC | Q15417 | |
Protein Name | Calponin-3 | |
Gene Name | CNN3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 329 | |
Subcellular Localization | ||
Protein Description | Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin, troponin C and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity.. | |
Protein Sequence | MTHFNKGPSYGLSAEVKNKIASKYDHQAEEDLRNWIEEVTGMSIGPNFQLGLKDGIILCELINKLQPGSVKKVNESSLNWPQLENIGNFIKAIQAYGMKPHDIFEANDLFENGNMTQVQTTLVALAGLAKTKGFHTTIDIGVKYAEKQTRRFDEGKLKAGQSVIGLQMGTNKCASQAGMTAYGTRRHLYDPKMQTDKPFDQTTISLQMGTNKGASQAGMLAPGTRRDIYDQKLTLQPVDNSTISLQMGTNKVASQKGMSVYGLGRQVYDPKYCAAPTEPVIHNGSQGTGTNGSEISDSDYQAEYPDEYHGEYQDDYPRDYQYSDQGIDY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTHFNKGPS ------CCCCCCCCC | 34.86 | 28857561 | |
6 | Acetylation | --MTHFNKGPSYGLS --CCCCCCCCCCCCC | 71.85 | - | |
6 | Acetylation | --MTHFNKGPSYGLS --CCCCCCCCCCCCC | 71.85 | 23236377 | |
6 | Malonylation | --MTHFNKGPSYGLS --CCCCCCCCCCCCC | 71.85 | 26320211 | |
6 | Ubiquitination | --MTHFNKGPSYGLS --CCCCCCCCCCCCC | 71.85 | 23000965 | |
9 | Phosphorylation | THFNKGPSYGLSAEV CCCCCCCCCCCCHHH | 40.27 | 21945579 | |
10 | Phosphorylation | HFNKGPSYGLSAEVK CCCCCCCCCCCHHHH | 25.81 | 21945579 | |
13 | Phosphorylation | KGPSYGLSAEVKNKI CCCCCCCCHHHHHHH | 20.30 | 21945579 | |
17 | Ubiquitination | YGLSAEVKNKIASKY CCCCHHHHHHHHHCC | 43.99 | - | |
17 | Ubiquitination | YGLSAEVKNKIASKY CCCCHHHHHHHHHCC | 43.99 | 23000965 | |
19 | Ubiquitination | LSAEVKNKIASKYDH CCHHHHHHHHHCCCH | 33.65 | 23000965 | |
23 | Acetylation | VKNKIASKYDHQAEE HHHHHHHCCCHHHHH | 45.75 | - | |
23 | Acetylation | VKNKIASKYDHQAEE HHHHHHHCCCHHHHH | 45.75 | 25825284 | |
23 | Ubiquitination | VKNKIASKYDHQAEE HHHHHHHCCCHHHHH | 45.75 | 23000965 | |
30 | Ubiquitination | KYDHQAEEDLRNWIE CCCHHHHHHHHHHHH | 66.42 | 27667366 | |
43 | Phosphorylation | IEEVTGMSIGPNFQL HHHHHCCCCCCCCCC | 26.24 | 21406692 | |
59 | S-nitrosocysteine | LKDGIILCELINKLQ CCCCCHHHHHHHHHC | 2.55 | - | |
59 | S-nitrosylation | LKDGIILCELINKLQ CCCCCHHHHHHHHHC | 2.55 | 19483679 | |
69 | Phosphorylation | INKLQPGSVKKVNES HHHHCCCCEEECCHH | 37.13 | 27499020 | |
71 | 2-Hydroxyisobutyrylation | KLQPGSVKKVNESSL HHCCCCEEECCHHHC | 53.34 | - | |
71 | Ubiquitination | KLQPGSVKKVNESSL HHCCCCEEECCHHHC | 53.34 | 27667366 | |
97 | Ubiquitination | IKAIQAYGMKPHDIF HHHHHHCCCCHHHCC | 22.21 | 22817900 | |
101 | Ubiquitination | QAYGMKPHDIFEAND HHCCCCHHHCCCHHH | 34.97 | 22817900 | |
102 | Ubiquitination | AYGMKPHDIFEANDL HCCCCHHHCCCHHHC | 56.66 | 22817900 | |
106 | Ubiquitination | KPHDIFEANDLFENG CHHHCCCHHHCHHCC | 12.23 | 22817900 | |
110 | Ubiquitination | IFEANDLFENGNMTQ CCCHHHCHHCCCCCH | 8.37 | 23000965 | |
112 | Ubiquitination | EANDLFENGNMTQVQ CHHHCHHCCCCCHHH | 39.54 | 23000965 | |
115 | Acetylation | DLFENGNMTQVQTTL HCHHCCCCCHHHHHH | 2.69 | - | |
115 | Ubiquitination | DLFENGNMTQVQTTL HCHHCCCCCHHHHHH | 2.69 | 23000965 | |
117 | Ubiquitination | FENGNMTQVQTTLVA HHCCCCCHHHHHHHH | 17.98 | - | |
117 | Ubiquitination | FENGNMTQVQTTLVA HHCCCCCHHHHHHHH | 17.98 | 23000965 | |
126 | Ubiquitination | QTTLVALAGLAKTKG HHHHHHHHHHHHCCC | 10.96 | 23000965 | |
131 | Ubiquitination | ALAGLAKTKGFHTTI HHHHHHHCCCCEEEE | 30.69 | 23000965 | |
143 | Ubiquitination | TTIDIGVKYAEKQTR EEEECCHHHHHHCCC | 33.26 | 22817900 | |
146 | Ubiquitination | DIGVKYAEKQTRRFD ECCHHHHHHCCCCCC | 42.48 | 23000965 | |
147 | 2-Hydroxyisobutyrylation | IGVKYAEKQTRRFDE CCHHHHHHCCCCCCC | 49.12 | - | |
147 | Ubiquitination | IGVKYAEKQTRRFDE CCHHHHHHCCCCCCC | 49.12 | 22817900 | |
151 | Ubiquitination | YAEKQTRRFDEGKLK HHHHCCCCCCCCCCC | 46.91 | 23000965 | |
156 | Acetylation | TRRFDEGKLKAGQSV CCCCCCCCCCCCCEE | 44.78 | - | |
156 | Ubiquitination | TRRFDEGKLKAGQSV CCCCCCCCCCCCCEE | 44.78 | - | |
156 | Acetylation | TRRFDEGKLKAGQSV CCCCCCCCCCCCCEE | 44.78 | 23236377 | |
156 | Ubiquitination | TRRFDEGKLKAGQSV CCCCCCCCCCCCCEE | 44.78 | 23000965 | |
158 | Methylation | RFDEGKLKAGQSVIG CCCCCCCCCCCEEEE | 54.69 | 24129315 | |
158 | Ubiquitination | RFDEGKLKAGQSVIG CCCCCCCCCCCEEEE | 54.69 | 23000965 | |
162 | Phosphorylation | GKLKAGQSVIGLQMG CCCCCCCEEEEEECC | 18.13 | 27499020 | |
166 | Ubiquitination | AGQSVIGLQMGTNKC CCCEEEEEECCCCHH | 1.86 | 23000965 | |
168 | Sulfoxidation | QSVIGLQMGTNKCAS CEEEEEECCCCHHHH | 9.57 | 30846556 | |
170 | Phosphorylation | VIGLQMGTNKCASQA EEEEECCCCHHHHHH | 26.60 | 22210691 | |
171 | Ubiquitination | IGLQMGTNKCASQAG EEEECCCCHHHHHHC | 31.51 | 21890473 | |
171 | Ubiquitination | IGLQMGTNKCASQAG EEEECCCCHHHHHHC | 31.51 | 23000965 | |
172 | Methylation | GLQMGTNKCASQAGM EEECCCCHHHHHHCC | 30.89 | - | |
172 | Ubiquitination | GLQMGTNKCASQAGM EEECCCCHHHHHHCC | 30.89 | 23000965 | |
175 | Phosphorylation | MGTNKCASQAGMTAY CCCCHHHHHHCCCCC | 29.99 | 23532336 | |
180 | Phosphorylation | CASQAGMTAYGTRRH HHHHHCCCCCCCCCC | 18.79 | 27251275 | |
182 | Phosphorylation | SQAGMTAYGTRRHLY HHHCCCCCCCCCCCC | 15.18 | 24927040 | |
184 | Phosphorylation | AGMTAYGTRRHLYDP HCCCCCCCCCCCCCC | 16.32 | 29978859 | |
186 | Ubiquitination | MTAYGTRRHLYDPKM CCCCCCCCCCCCCCC | 24.81 | 23000965 | |
189 | Phosphorylation | YGTRRHLYDPKMQTD CCCCCCCCCCCCCCC | 24.87 | 29759185 | |
191 | Ubiquitination | TRRHLYDPKMQTDKP CCCCCCCCCCCCCCC | 22.06 | 21890473 | |
191 | Ubiquitination | TRRHLYDPKMQTDKP CCCCCCCCCCCCCCC | 22.06 | 23000965 | |
192 | 2-Hydroxyisobutyrylation | RRHLYDPKMQTDKPF CCCCCCCCCCCCCCC | 40.52 | - | |
192 | Ubiquitination | RRHLYDPKMQTDKPF CCCCCCCCCCCCCCC | 40.52 | 23000965 | |
197 | Acetylation | DPKMQTDKPFDQTTI CCCCCCCCCCCCCEE | 51.47 | 23236377 | |
197 | Ubiquitination | DPKMQTDKPFDQTTI CCCCCCCCCCCCCEE | 51.47 | 23000965 | |
205 | Phosphorylation | PFDQTTISLQMGTNK CCCCCEEEEEECCCC | 15.51 | 27251275 | |
205 | Ubiquitination | PFDQTTISLQMGTNK CCCCCEEEEEECCCC | 15.51 | 23000965 | |
210 | Ubiquitination | TISLQMGTNKGASQA EEEEEECCCCCCHHC | 28.54 | 21890473 | |
210 | Ubiquitination | TISLQMGTNKGASQA EEEEEECCCCCCHHC | 28.54 | 21890473 | |
210 | Phosphorylation | TISLQMGTNKGASQA EEEEEECCCCCCHHC | 28.54 | - | |
210 | Ubiquitination | TISLQMGTNKGASQA EEEEEECCCCCCHHC | 28.54 | 23000965 | |
212 | Ubiquitination | SLQMGTNKGASQAGM EEEECCCCCCHHCCC | 56.54 | 23000965 | |
215 | Ubiquitination | MGTNKGASQAGMLAP ECCCCCCHHCCCCCC | 29.27 | - | |
215 | Phosphorylation | MGTNKGASQAGMLAP ECCCCCCHHCCCCCC | 29.27 | 28857561 | |
215 | Ubiquitination | MGTNKGASQAGMLAP ECCCCCCHHCCCCCC | 29.27 | 23000965 | |
219 | Sulfoxidation | KGASQAGMLAPGTRR CCCHHCCCCCCCCCC | 3.02 | 28465586 | |
224 | Phosphorylation | AGMLAPGTRRDIYDQ CCCCCCCCCCCCCCC | 22.82 | 28857561 | |
232 | Ubiquitination | RRDIYDQKLTLQPVD CCCCCCCCCEEEECC | 40.31 | 23000965 | |
234 | Phosphorylation | DIYDQKLTLQPVDNS CCCCCCCEEEECCCC | 30.31 | 24043423 | |
241 | Phosphorylation | TLQPVDNSTISLQMG EEEECCCCEEEEEEC | 23.74 | 29514088 | |
242 | Phosphorylation | LQPVDNSTISLQMGT EEECCCCEEEEEECC | 22.34 | 29514088 | |
244 | Phosphorylation | PVDNSTISLQMGTNK ECCCCEEEEEECCCH | 16.79 | 29514088 | |
247 | Sulfoxidation | NSTISLQMGTNKVAS CCEEEEEECCCHHHC | 9.67 | 30846556 | |
249 | Phosphorylation | TISLQMGTNKVASQK EEEEEECCCHHHCCC | 26.90 | 24173317 | |
251 | Ubiquitination | SLQMGTNKVASQKGM EEEECCCHHHCCCCC | 38.73 | 23000965 | |
254 | Phosphorylation | MGTNKVASQKGMSVY ECCCHHHCCCCCCEE | 35.10 | 24117733 | |
256 | Ubiquitination | TNKVASQKGMSVYGL CCHHHCCCCCCEECC | 54.83 | 23000965 | |
256 | Ubiquitination | TNKVASQKGMSVYGL CCHHHCCCCCCEECC | 54.83 | 21890473 | |
258 | Sulfoxidation | KVASQKGMSVYGLGR HHHCCCCCCEECCCC | 2.93 | 30846556 | |
259 | Phosphorylation | VASQKGMSVYGLGRQ HHCCCCCCEECCCCC | 22.36 | 27499020 | |
261 | Phosphorylation | SQKGMSVYGLGRQVY CCCCCCEECCCCCCC | 10.18 | 27273156 | |
272 | Phosphorylation | RQVYDPKYCAAPTEP CCCCCCCCCCCCCCC | 7.84 | 25999147 | |
277 | Phosphorylation | PKYCAAPTEPVIHNG CCCCCCCCCCEEECC | 48.47 | 27251275 | |
282 | Phosphorylation | APTEPVIHNGSQGTG CCCCCEEECCCCCCC | 32.60 | 32142685 | |
285 | Phosphorylation | EPVIHNGSQGTGTNG CCEEECCCCCCCCCC | 30.65 | 23927012 | |
288 | Phosphorylation | IHNGSQGTGTNGSEI EECCCCCCCCCCCCC | 32.94 | 25247763 | |
290 | Phosphorylation | NGSQGTGTNGSEISD CCCCCCCCCCCCCCC | 35.92 | 23927012 | |
293 | Phosphorylation | QGTGTNGSEISDSDY CCCCCCCCCCCCCCC | 33.55 | 28387310 | |
296 | Phosphorylation | GTNGSEISDSDYQAE CCCCCCCCCCCCCCC | 27.32 | 23927012 | |
298 | Phosphorylation | NGSEISDSDYQAEYP CCCCCCCCCCCCCCC | 31.28 | 25247763 | |
300 | Phosphorylation | SEISDSDYQAEYPDE CCCCCCCCCCCCCCC | 17.36 | 28387310 | |
304 | Phosphorylation | DSDYQAEYPDEYHGE CCCCCCCCCCCCCCC | 20.99 | 23927012 | |
308 | Phosphorylation | QAEYPDEYHGEYQDD CCCCCCCCCCCCCCC | 23.62 | - | |
316 | Phosphorylation | HGEYQDDYPRDYQYS CCCCCCCCCCCCCCC | 14.41 | 20736484 | |
320 | Phosphorylation | QDDYPRDYQYSDQGI CCCCCCCCCCCCCCC | 15.61 | 23403867 | |
322 | Phosphorylation | DYPRDYQYSDQGIDY CCCCCCCCCCCCCCC | 14.16 | 28152594 | |
323 | Phosphorylation | YPRDYQYSDQGIDY- CCCCCCCCCCCCCC- | 14.13 | 21082442 | |
329 | Phosphorylation | YSDQGIDY------- CCCCCCCC------- | 20.66 | 23403867 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNN3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNN3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CARM1_HUMAN | CARM1 | physical | 26186194 | |
C1TM_HUMAN | MTHFD1L | physical | 26344197 | |
CARM1_HUMAN | CARM1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-261, AND MASSSPECTROMETRY. |